FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1269009: Amikacin sulfate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3240013 Amikacin sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
473923014 Amikacin sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730925017 Amikacin sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2638571000005111 Amikacinsulfat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amikacin sulfate Is a Product containing amikacin (medicinal product) false Inferred relationship Some
Amikacin sulfate Is a Substance with aminoglycoside structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Amikacin sulfate Is a Amikacin (substance) false Inferred relationship Some
Amikacin sulfate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Amikacin (substance) true Inferred relationship Some
Amikacin sulfate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
amikacinsulfat 100 mg/2 ml pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amikacin sulfate Inferred relationship Some
amikacinsulfat 1 gram/4 ml injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amikacin sulfate Inferred relationship Some
amikacin 100 mg/2 ml injektionsvæske til børn The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amikacin sulfate Inferred relationship Some
amikacin 250 mg/ml injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amikacin sulfate Inferred relationship Some
Product containing precisely amikacin (as amikacin sulfate) 100 milligram/2 milliliter conventional release solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Amikacin sulfate Inferred relationship Some 1
Product containing precisely amikacin (as amikacin sulfate) 500 milligram/2 milliliter conventional release solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Amikacin sulfate Inferred relationship Some 1
Product containing precisely amikacin (as amikacin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amikacin sulfate Inferred relationship Some 1
Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amikacin sulfate Inferred relationship Some 1
Amikacin sulfate 10 mg/mL eye drops The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amikacin sulfate Inferred relationship Some 1
Amikacin sulfate 10 mg/mL eye drops This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amikacin sulfate Inferred relationship Some 1
Product containing precisely amikacin (as amikacin sulfate) 125 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amikacin sulfate Inferred relationship Some 1
Amikacin (as amikacin sulfate) 5 mg/mL solution for infusion The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amikacin sulfate Inferred relationship Some 1
Amikacin (as amikacin sulfate) 250 mg/mL solution for infusion and/or injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amikacin sulfate Inferred relationship Some 1
Amikacin sulfate liposome This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Amikacin sulfate Inferred relationship Some

This concept is not in any reference sets

Back to Start